ORLISTAT
Manner of administration:Oral
Restriction
Indication: Obesity
Treatment phase: Initial treatment
Restriction
Indication: Obesity
Treatment phase: Continuing treatment (3 to 6 months following commencement)
Restriction
Indication: Obesity
Treatment phase: Continuing treatment (6 to 12 months following commencement)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 84 | # of repeats: 2 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
| Xenical | DPMQ: $136.45 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||